140 related articles for article (PubMed ID: 9755574)
1. [Occult breast cancer].
Vasile D; Palade R; Voiculescu D
Chirurgia (Bucur); 1998; 93(4):247-53. PubMed ID: 9755574
[TBL] [Abstract][Full Text] [Related]
2. Occult breast cancer presenting as axillary metastases.
Yamaguchi H; Ishikawa M; Hatanaka K; Uekusa T; Ishimaru M; Nagawa H
Breast; 2006 Apr; 15(2):259-62. PubMed ID: 15996865
[TBL] [Abstract][Full Text] [Related]
3. Prognosis of occult breast carcinoma presenting as isolated axillary nodal metastasis.
Varadarajan R; Edge SB; Yu J; Watroba N; Janarthanan BR
Oncology; 2006; 71(5-6):456-9. PubMed ID: 17690561
[TBL] [Abstract][Full Text] [Related]
4. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
5. Axillary nodal metastasis of occult breast primary cancer.
Tamiolakis D; Antoniou C
Chirurgia (Bucur); 2008; 103(4):467-71. PubMed ID: 18780622
[TBL] [Abstract][Full Text] [Related]
6. Preoperative axillary staging in breast cancer-saving time and resources.
Tahir M; Osman KA; Shabbir J; Rogers C; Suarez R; Reynolds T; Bucknall T
Breast J; 2008; 14(4):369-71. PubMed ID: 18540958
[TBL] [Abstract][Full Text] [Related]
7. [Axillary metastases of unknown primary carcinoma].
Ellend A; Obwegeser R; Auerbach L; Czerwenka K; Kubista E
Geburtshilfe Frauenheilkd; 1996 Apr; 56(4):209-13. PubMed ID: 8682287
[TBL] [Abstract][Full Text] [Related]
8. Regional nodal recurrence in the management of breast cancer patients with one to three positive axillary lymph nodes. Outcome of patients following tangential irradiation without a separate nodal field.
Stranzl H; Peintinger F; Ofner P; Prettenhofer U; Mayer R; Hackl A
Strahlenther Onkol; 2004 Oct; 180(10):623-8. PubMed ID: 15480510
[TBL] [Abstract][Full Text] [Related]
9. [Exploration of the extent of axillary dissection for patients with node positive primary breast cancer].
Ouyang T; Li JF; Wang TF; Lin BY
Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(5):298-300. PubMed ID: 15842936
[TBL] [Abstract][Full Text] [Related]
10. Drug concentrations in axillary lymph nodes after lymphatic chemotherapy on patients with breast cancer.
Chen J; Wang L; Yao Q; Ling R; Li K; Wang H
Breast Cancer Res; 2004; 6(4):R474-7. PubMed ID: 15217515
[TBL] [Abstract][Full Text] [Related]
11. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.
Pendas S; Dauway E; Cox CE; Giuliano R; Ku NN; Schreiber RH; Reintgen DS
Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.
Keam B; Im SA; Kim HJ; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Cho N; Moon WK; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
Breast Cancer Res Treat; 2009 Jul; 116(1):153-60. PubMed ID: 18787948
[TBL] [Abstract][Full Text] [Related]
13. A patient with occult breast cancer presenting with an axillary lymph node metastasis and a synchronous contralateral breast cancer.
Yirmibeşoğlu E; Tekin E; Memiş L; Yamaç D; Taneri F; Erkal HS
Breast; 2005 Apr; 14(2):157-62. PubMed ID: 15767187
[TBL] [Abstract][Full Text] [Related]
14. Occult breast carcinoma presenting as an axillary mass.
Scoggins CR; Vitola JV; Sandler MP; Atkinson JB; Frexes-Steed M
Am Surg; 1999 Jan; 65(1):1-5. PubMed ID: 9915521
[TBL] [Abstract][Full Text] [Related]
15. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.
Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U
J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
[TBL] [Abstract][Full Text] [Related]
17. Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy?
Specht MC; Fey JV; Borgen PI; Cody HS
J Am Coll Surg; 2005 Jan; 200(1):10-4. PubMed ID: 15631914
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the contralateral breast in patients with ipsilateral breast carcinoma: the role of mammography.
Muttarak M; Pojchamarnwiputh S; Padungchaichote W; Chaiwun B
Singapore Med J; 2002 May; 43(5):229-33. PubMed ID: 12188073
[TBL] [Abstract][Full Text] [Related]
19. T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy.
Garg AK; Strom EA; McNeese MD; Buzdar AU; Hortobagyi GN; Kuerer HM; Perkins GH; Singletary SE; Hunt KK; Sahin A; Schechter N; Valero V; Tucker SL; Buchholz TA
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):138-45. PubMed ID: 15093909
[TBL] [Abstract][Full Text] [Related]
20. Management and outcomes of isolated axillary node recurrence in breast cancer.
Konkin DE; Tyldesley S; Kennecke H; Speers CH; Olivotto IA; Davis N
Arch Surg; 2006 Sep; 141(9):867-72; discussion 872-4. PubMed ID: 16983030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
